Lynch Casey 4
4 · Cortexyme, Inc. · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Cortexyme, Inc.CRTX
Lynch Casey
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-03+440,000→ 440,000 totalExercise: $13.39Exp: 2032-01-02→ Common Stock (440,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the date of grant, such that the total number of shares shall be fully vested on the four-year anniversary of the date of grant.